Notable Upgrades: Cerner (CERN), Ritter Pharmaceuticals (RTTR), Bristol-Myers Squibb (BMY), Orbotech (ORBK)

Cerner Corporation (CERN) was reiterated an ‘Outperform’ by RBC Capital Markets analysts on Wednesday. The broker also raised its price target on the stock to $70 from $65. — In a report published Wednesday, Chardan Capital Markets analysts initiated coverage on Ritter Pharmaceuticals, Inc. (RTTR) with a ‘Buy’ rating and $3.00 price target. RTTR has […] View the full post at: Notable Upgrades: Cerner (CERN), Ritter Pharmaceuticals (RTTR), Bristol-Myers Squibb (BMY), Orbotech (ORBK) Related posts: Bristol-Myers Squibb Increases ImClone’s Tender Offer to $62 per Share Bristol Myers Acquires Partner Medarex for $2.4B Apple’s (AAPL) Short Interest Nosedives